Truncated Class 1 Integron Gene Cassette Arrays Contribute to Antimicrobial Resistance of Diarrheagenic


Journal

BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173

Informations de publication

Date de publication:
2020
Historique:
received: 31 07 2019
accepted: 30 12 2019
entrez: 25 2 2020
pubmed: 25 2 2020
medline: 25 11 2020
Statut: epublish

Résumé

Class 1 integrons (c1-integrons) are associated with multidrug resistance in diarrheagenic

Identifiants

pubmed: 32090095
doi: 10.1155/2020/4908189
pmc: PMC7013361
doi:

Substances chimiques

Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4908189

Informations de copyright

Copyright © 2020 Akiko Kubomura et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest regarding the publication of this article.

Références

Diagn Microbiol Infect Dis. 2009 Oct;65(2):214-6
pubmed: 19748438
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Clin Microbiol Rev. 1998 Jan;11(1):142-201
pubmed: 9457432
Antimicrob Agents Chemother. 2011 Jul;55(7):3140-9
pubmed: 21518841
Jpn J Infect Dis. 2017 Sep 25;70(5):507-512
pubmed: 28367879
Curr Opin Infect Dis. 2011 Oct;24(5):478-83
pubmed: 21857511
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Mol Med Rep. 2013 Oct;8(4):1251-5
pubmed: 23939784
J Antimicrob Chemother. 2005 Dec;56(6):1019-24
pubmed: 16239286
Microbiol Immunol. 2004;48(9):639-45
pubmed: 15383699
Ann Clin Microbiol Antimicrob. 2004 Jul 08;3:12
pubmed: 15242512
Kansenshogaku Zasshi. 2002 Nov;76(11):911-20
pubmed: 12508474
J Bacteriol. 2001 Jan;183(1):235-49
pubmed: 11114922
Antimicrob Agents Chemother. 2008 Sep;52(9):3099-105
pubmed: 18591274
J Antimicrob Chemother. 2006 Aug;58(2):305-9
pubmed: 16782743
Lancet Infect Dis. 2016 Mar;16(3):284-5
pubmed: 26774245
Sci Rep. 2016 Apr 11;6:24321
pubmed: 27062991
FEMS Microbiol Rev. 2009 Jul;33(4):757-84
pubmed: 19416365
Mob Genet Elements. 2012 Sep 1;2(5):211-223
pubmed: 23550063
J Infect Dis. 2003 Jan 15;187(2):251-9
pubmed: 12552449
Antimicrob Agents Chemother. 2006 Feb;50(2):791-5
pubmed: 16436748
Appl Environ Microbiol. 2011 Oct;77(20):7104-12
pubmed: 21856835
Am J Trop Med Hyg. 2009 Aug;81(2):296-301
pubmed: 19635887
PLoS One. 2013 Sep 30;8(9):e75805
pubmed: 24098729
Emerg Infect Dis. 2009 Mar;15(3):388-96
pubmed: 19239750
J Antimicrob Chemother. 2005 May;55(5):639-44
pubmed: 15761064
FEMS Microbiol Lett. 2000 Mar 1;184(1):53-6
pubmed: 10689165
FEMS Microbiol Lett. 2006 Mar;256(2):251-7
pubmed: 16499614
Microbiol Immunol. 2015 Sep;59(9):516-25
pubmed: 26223152
Southeast Asian J Trop Med Public Health. 2008 Mar;39(2):279-87
pubmed: 18564714
Clin Microbiol Infect. 2014 Jan;20(1):52-8
pubmed: 23521436
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2972-80
pubmed: 26953207
Can J Microbiol. 2014 Apr;60(4):237-42
pubmed: 24693982

Auteurs

Akiko Kubomura (A)

Kawasaki City Institute for Public Health, 3-25-13 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan.

Tsuyoshi Sekizuka (T)

Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan.

Daisuke Onozuka (D)

Department of Preventive Medicine and Epidemiology, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka 564-8565, Japan.

Koichi Murakami (K)

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.

Hirokazu Kimura (H)

School of Medical Technology, Faculty of Health Sciences, Gunma Paz University, 1-7-1 Tonyamachi, Takasaki-shi, Gunma 370-0006, Japan.

Masahiro Sakaguchi (M)

Department of Veterinary Microbiology I, School of Veterinary Medicine, Azabu University, 1-17-71 Fuchinobe, Chuo-ku, Sagamihara, Kanagawa 252-5201, Japan.

Kazunori Oishi (K)

Toyama Institute of Health, 17-1 Nakataikoyama, Imizu, Toyama 939-0363, Japan.

Shinichiro Hirai (S)

Infectious Disease Surveillance Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama, Tokyo 208-0011, Japan.

Makoto Kuroda (M)

Pathogen Genomics Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku, Tokyo 162-8640, Japan.

Nobuhiko Okabe (N)

Kawasaki City Institute for Public Health, 3-25-13 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa 210-0821, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH